US drawback claims boom despite complex tariff regime
By Bradley Dress, Eliana Hubacker ( July 10, 2026, 20:02 GMT | Comment) -- Over the past year, a little-known program offering refunds for imported goods that are re-exported has dramatically grown — powered by new companies and industries hit by sweeping tariffs — but the Trump administration has also toughened eligibility requirements and made it more complex. US Customs and Border Protection offers drawback claims for imported goods that are re-exported or added to a good that is later exported, allowing for a refund of up to 99 percent on eligible merchandise. The past decade of shifting tariffs spanning more and more industries has boosted the use of this program as a secure way to get money back. But President Donald Trump has limited the availability of drawback claims for all goods subject to Section 232 tariffs, with a few exceptions.Over the past year, a little-known program offering refunds for imported goods that are re-exported has dramatically grown — powered by new companies and industries hit by sweeping tariffs — but the Trump administration has also reduced its eligibility and made it more complex. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.